CANY
ENOV icon

Caxton Associates (New York)’s Enovis ENOV Stock Holding History

Caxton Associates (New York)’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,246
Closed -$237K – 559
2024
Q2 		$237K Buy
+5,246
New +$272K 0.01% 423
2023
Q2 		– Sell
-28,557
Closed -$1.53M – 544
2023
Q1 		$1.53M Buy
28,557
+5,718
+25% +$331K 0.23% 80
2022
Q4 		$1.22M Buy
22,839
+544
+2% +$28.1K 0.08% 86
2022
Q3 		$1.03M Buy
+22,295
New +$1.21M 0.14% 108
2017
Q4 		– Sell
-29,050
Closed -$2.08M – 383
2017
Q3 		$2.08M Buy
29,050
+5,810
+25% +$404K 0.07% 194
2017
Q2 		$1.57M Buy
+23,240
New +$1.58M 0.06% 195
2013
Q3 		– Sell
-46,248
Closed -$4.15M – 186
2013
Q2 		$4.15M Buy
+46,248
New +$3.81M 0.21% 94

Other funds holding ENOV

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caxton Associates (New York)'s ENOV Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Enovis (ENOV) in Q3 2024, closing a stake of 5,246 shares — an estimated $237K sold.

Caxton Associates (New York) first reported a position in ENOV in Q2 2013 and held it in 7 quarters. The position peaked at $4.15M in Q2 2013. 283 funds tracked by Wall St. Rank hold ENOV as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Enovis position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 5,246 Enovis shares in Q3 2024, an estimated $237K.
  • Caxton Associates (New York) first reported a position in Enovis in Q2 2013 and held it in 7 quarters.
  • Caxton Associates (New York)'s Enovis position peaked at $4.15M in Q2 2013.
  • 283 funds tracked by Wall St. Rank held Enovis as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.